- Prev
- 1
- Next
- Filings
-
Filing Tables
- Filing Analysis
- News
- Transcripts
- Patents
December 31, 2023 | December 31, 2022 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 374,038 | $ | 240,943 | ||||
Short-term marketable securities | 79,944 | 130,941 | ||||||
Restricted cash | — | 50 | ||||||
Prepaid expenses and other current assets | 24,297 | 16,021 | ||||||
Total current assets | 478,279 | 387,955 | ||||||
Long-term marketable securities | 9,845 | 23,511 | ||||||
Property and equipment, net | 1,790 | 2,411 | ||||||
Operating lease right-of-use assets | 5,068 | 8,231 | ||||||
Restricted cash | 1,213 | 1,213 | ||||||
Other assets | — | 2,913 | ||||||
Total assets | $ | 496,195 | $ | 426,234 | ||||
Liabilities, Convertible Preferred Stock, and Stockholders’ Equity (Deficit) | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 337 | $ | 7,147 | ||||
Accrued liabilities | 21,257 | 11,536 | ||||||
Early exercise liability, current portion | 139 | 1,644 | ||||||
Operating lease liabilities, current portion | 3,378 | 3,370 | ||||||
Total current liabilities | 25,111 | 23,697 | ||||||
Operating lease liabilities, net of current portion | 1,853 | 5,072 | ||||||
Early exercise liability, net of current portion | 155 | 628 | ||||||
Total liabilities | 27,119 | 29,397 | ||||||
Commitments and contingencies (Note 7) | ||||||||
Convertible preferred stock, $0.0001 par value; 50,000 and 820,349 shares authorized as of December 31, 2023 and December 31, 2022, respectively; no and 104,417 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | — | 843,687 | ||||||
Stockholders’ equity (deficit): | ||||||||
Common stock, $0.0001 par value; 700,000 and 1,210,000 shares authorized as of December 31, 2023 and December 31, 2022 respectively; 158,832 and 32,612 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 16 | 3 | ||||||
Additional paid-in capital | 1,172,570 | 21,430 | ||||||
Accumulated other comprehensive loss | (76) | (774) | ||||||
Accumulated deficit | (703,434) | (467,509) | ||||||
Total stockholders’ equity (deficit) | 469,076 | (446,850) | ||||||
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit) | $ | 496,195 | $ | 426,234 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.